Scabies cure rates under the microscope: national study reveals treatment success

NCT ID NCT07305961

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Italian study looked at over 1,300 people with scabies to see how often the first treatment cured them. Researchers also tracked how many scabies cases occurred over three years and analyzed patterns by age and ethnicity. The study did not test a new drug but collected real-world data on current treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,332 people

The number who actually took part.

Started

Jan 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients with scabies and their close contacts (household/partners) afferent to the outpatient clinics of participating Italian centers during the duration of the study will be included in the study.

Ages

6 months to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients of any age with clinical and/or dermoscopic and/or microscopic diagnosis of scabies. * Close contacts (household/relatives) of patients diagnosed with scabies. * Obtaining informed consent. Exclusion Criteria: * There are no exclusion criteria.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Scabies are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AOU Maggiore della Carità

    Novara, 28100, Italy

  • AOU Policlinico Gaetano Martino

    Messina, Maine, 98124, Italy

  • AOU S.Maria della Misericordia

    Udine, UD, 33100, Italy

  • AOU San Giovanni di Dio

    Cagliari, Italy, CA, 09123, Italy

  • APSS - Ospedale Santa Chiara

    Trento, Italy/Trento, 38123, Italy

  • ASL Toscana Nord Ovest

    Lucca, LU, 55100, Italy

  • ASST LECCO Alessandro Manzoni

    Lecco, LC, 23900, Italy

  • ASST Papa Giovanni XXIII

    Bergamo, BG, 24127, Italy

  • AUSL Della Romagna

    Ravenna, RA, 48121, Italy

  • Azienda Ospedaliera Universitaria Meyer IRCCS

    Florence, FI, 50139, Italy

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, Michigan, 20122, Italy

  • Fondazione Policlinico San Matteo IRCCS

    Pavia, PV, 27100, Italy

  • Fondazione Policlinico Tor Vergata

    Roma, RM, 00133, Italy

  • IRCCS AOU di Bologna

    Bologna, BO, 40138, Italy

  • Istituto San Gallicano

    Roma, RM, 00144, Italy

  • Ospedale Cardinal Massaia

    Asti, AT, 14100, Italy

  • Ospedale Civico Maggiore Borgo Trento

    Verona, VR, 37126, Italy

  • Ospedale Policlinico San Martino

    Genova, GE, 16132, Italy

  • Ospedale Versilia

    Lido di Camaiore, LU, 55041, Italy

  • Ospedali Riuniti di Foggia

    Foggia, FG, 71122, Italy

  • Regina Margherita Children's Hospital, Città della Salute e della Scienza di Torino

    Torino, TO, 10126, Italy

  • USL Toscana Centro

    Florence, FI, 50100, Italy

  • Università VANVITELLI

    Naples, 80138, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.